AJ Lanigan: Indeed. The Truth is, pharma firms are producing major dollars with treatment options like Keytruda and Opdivo that offer with PD-1 and PD-L1. Below’s the super amazing aspect: think about checkpoints as targeted traffic alerts. You don’t want an immune method that’s jogging wild just like a freight waiting for link from Social Bookmarking